Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
66,729,680
-
Total 13F shares
-
10,168,502
-
Share change
-
-3,439,291
-
Total reported value
-
$20,694,831
-
Put/Call ratio
-
30%
-
Price per share
-
$2.04
-
Number of holders
-
101
-
Value change
-
-$6,577,397
-
Number of buys
-
46
-
Number of sells
-
56
Institutional Holders of INOVIO PHARMACEUTICALS, INC. - Common Stock (INO) as of Q2 2025
As of 30 Jun 2025,
INOVIO PHARMACEUTICALS, INC. - Common Stock (INO) was held by
101 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,168,502 shares.
The largest 10 holders included
VANGUARD GROUP INC, Deep Track Capital, LP, BANK OF AMERICA CORP /DE/, BlackRock, Inc., GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, MILLENNIUM MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, NORTHERN TRUST CORP, and UBS Group AG.
This page lists
101
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.